Brind.
  1. Developments include Roche and Genentech rolling out phenomaps, a partnership between Gibson and MIT, an MIT/Nvidia platform collaboration, and a Sanofi milestone achievement.

A new AI biology venture, co-founded by Patrick Collison, is competing in the AI drug discovery market.

1 report, 1 independent Updated Jun 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

A new AI biology venture, co-founded by Patrick Collison, is competing in the AI drug discovery market.

Who's involved

What this event is mainly about
ARC InstitutePatrick CollisonIsomorphic Labs

Keep exploring

Part of

Developments include Roche and Genentech rolling out phenomaps, a partnership between Gibson and MIT, an MIT/Nvidia platform collaboration, and a Sanofi milestone achievement. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped